CBLB and melanoma: More importantly, administration of low‐dose warfarin, which inhibits TAM receptor activity in vivo, markedly reduced melanoma metastases to the lungs and distal organs in Cbl‐b+/+ and Cbl‐b+/−mice but had no apparent effect on Cbl‐b‐defective mice.